Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery
RecruitingNCT06280092Phase: EARLY_PHASE1Started 2024-12-23
Summary
This study is a non-randomized, open label, phase 1 clinical trial to evaluate the fesibility and safety of intrathalamic delivery of MSCs during standard of care DBS surgery for epilepsy. Subjects w
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
75 Years
Locations
Mayo ClinicJacksonville, Florida, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06280092